Skip to main content

Published locations for Empagliflozin first antidiabetes drug to gain cardioprotective indication

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Empagliflozin first antidiabetes drug to gain cardioprotective indication

User login

  • Reset your password
  • /content/empagliflozin-first-antidiabetes-drug-gain-cardioprotective-indication
  • /familypracticenews/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain
  • /ehospitalistnews/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain-cardioprotective
  • /internalmedicinenews/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain
  • /clinicalendocrinologynews/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain
  • /ecardiologynews/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain-cardioprotective
  • /cardiology/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain-cardioprotective
  • /endocrinology/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain-cardioprotective
  • /internalmedicine/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain-cardioprotective
  • /familymedicine/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain-cardioprotective
  • /type-2-diabetes-icymi/article/119409/diabetes/empagliflozin-first-antidiabetes-drug-gain